Wahlund LO - Search Results

1

Genetic association of CDC2 with cerebrospinal fluid tau in Alzheimer's disease.

Johansson A, Zetterberg H, Hampel H, Buerger K, Prince JA, Minthon L, Wahlund LO, Blennow K. Johansson A, et al. Among authors: wahlund lo. Dement Geriatr Cogn Disord. 2005;20(6):367-74. doi: 10.1159/000088634. Epub 2005 Sep 29. Dement Geriatr Cogn Disord. 2005. PMID: 16192727

2

Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease.

Lannfelt L, Basun H, Wahlund LO, Rowe BA, Wagner SL. Lannfelt L, et al. Among authors: wahlund lo. Nat Med. 1995 Aug;1(8):829-32. doi: 10.1038/nm0895-829. Nat Med. 1995. PMID: 7585189

3

Amyloid beta-peptide in cerebrospinal fluid in individuals with the Swedish Alzheimer amyloid precursor protein mutation.

Lannfelt L, Basun H, Vigo-Pelfrey C, Wahlund LO, Winblad B, Lieberburg I, Schenk D. Lannfelt L, et al. Among authors: wahlund lo. Neurosci Lett. 1995 Oct 27;199(3):203-6. doi: 10.1016/0304-3940(95)12059-d. Neurosci Lett. 1995. PMID: 8577398

4

Biological markers and diagnostic investigations in Alzheimer's disease.

Wahlund LO. Wahlund LO. Acta Neurol Scand Suppl. 1996;165:85-91. doi: 10.1111/j.1600-0404.1996.tb05876.x. Acta Neurol Scand Suppl. 1996. PMID: 8740993 Review.

5

Increasing cerebrospinal fluid tau levels in a subgroup of Alzheimer patients with apolipoprotein E allele epsilon 4 during 14 months follow-up.

Blomberg M, Jensen M, Basun H, Lannfelt L, Wahlund LO. Blomberg M, et al. Among authors: wahlund lo. Neurosci Lett. 1996 Aug 23;214(2-3):163-6. doi: 10.1016/0304-3940(96)12905-0. Neurosci Lett. 1996. PMID: 8878109

6

Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation.

Almkvist O, Basun H, Wagner SL, Rowe BA, Wahlund LO, Lannfelt L. Almkvist O, et al. Among authors: wahlund lo. Arch Neurol. 1997 May;54(5):641-4. doi: 10.1001/archneur.1997.00550170111022. Arch Neurol. 1997. PMID: 9152122

7

Cerebrospinal fluid apolipoprotein E (apoE) levels in Alzheimer's disease patients are increased at follow up and show a correlation with levels of tau protein.

Lindh M, Blomberg M, Jensen M, Basun H, Lannfelt L, Engvall B, Scharnagel H, März W, Wahlund LO, Cowburn RF. Lindh M, et al. Among authors: wahlund lo. Neurosci Lett. 1997 Jun 27;229(2):85-8. doi: 10.1016/s0304-3940(97)00429-1. Neurosci Lett. 1997. PMID: 9223597

8

EEG slowing and cerebrospinal fluid tau levels in patients with cognitive decline.

Jelic V, Blomberg M, Dierks T, Basun H, Shigeta M, Julin P, Jensen M, Lannfelt L, Winblad B, Wahlund LO. Jelic V, et al. Among authors: wahlund lo. Neuroreport. 1998 Jan 5;9(1):157-60. doi: 10.1097/00001756-199801050-00032. Neuroreport. 1998. PMID: 9592068

9

Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease.

Eriksdotter Jönhagen M, Nordberg A, Amberla K, Bäckman L, Ebendal T, Meyerson B, Olson L, Seiger, Shigeta M, Theodorsson E, Viitanen M, Winblad B, Wahlund LO. Eriksdotter Jönhagen M, et al. Among authors: wahlund lo. Dement Geriatr Cogn Disord. 1998 Sep-Oct;9(5):246-57. doi: 10.1159/000017069. Dement Geriatr Cogn Disord. 1998. PMID: 9701676 Clinical Trial.

10

White matter lesions in Alzheimer patients are influenced by apolipoprotein E genotype.

Bronge L, Fernaeus SE, Blomberg M, Ingelson M, Lannfelt L, Isberg B, Wahlund LO. Bronge L, et al. Among authors: wahlund lo. Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):89-96. doi: 10.1159/000017107. Dement Geriatr Cogn Disord. 1999. PMID: 10026381 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters